Phytanix Bio Publishes New Investor Deck Highlighting Strategic Vision and Growth Potential
July 30, 2024
NEW YORK and SANTA BARBARA, Calif., July 30, 2024 – Phytanix Bio, a pioneering preclinical stage pharmaceutical company dedicated to the development of therapeutics based